A detailed history of Citizens Financial Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Citizens Financial Group Inc holds 32,995 shares of BMY stock, worth $1.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
32,995
Previous 35,203 6.27%
Holding current value
$1.91 Million
Previous $1.46 Million 16.84%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$39.66 - $51.75 $87,569 - $114,264
-2,208 Reduced 6.27%
32,995 $1.71 Million
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $324,817 - $427,629
8,070 Added 29.74%
35,203 $1.46 Million
Q1 2024

May 17, 2024

SELL
$47.98 - $54.4 $26,868 - $30,464
-560 Reduced 2.02%
27,133 $1.47 Million
Q4 2023

Feb 02, 2024

BUY
$48.48 - $57.85 $79,798 - $95,221
1,646 Added 6.32%
27,693 $1.42 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $195,552 - $218,657
-3,378 Reduced 11.48%
26,047 $1.51 Million
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $42,685 - $47,395
670 Added 2.33%
29,425 $1.88 Million
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $3,285 - $3,726
-50 Reduced 0.17%
28,755 $1.99 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $148,875 - $176,289
-2,174 Reduced 7.02%
28,805 $2.07 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $40 - $23,743
309 Added 1.01%
30,979 $2.2 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $228,535 - $251,697
3,147 Added 11.43%
30,670 $2.36 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $56,869 - $68,191
-925 Reduced 3.25%
27,523 $2.01 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $148,984 - $173,680
-2,778 Reduced 8.9%
28,448 $1.75 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $79,701 - $93,360
-1,347 Reduced 4.14%
31,226 $1.85 Million
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $67,110 - $73,083
1,084 Added 3.44%
32,573 $2.18 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $31,568 - $35,505
532 Added 1.72%
31,489 $1.99 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $72,810 - $82,507
-1,261 Reduced 3.91%
30,957 $1.92 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $62,598 - $69,367
1,090 Added 3.5%
32,218 $1.93 Million
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $104,541 - $122,219
-1,907 Reduced 5.77%
31,128 $1.83 Million
Q1 2020

May 08, 2020

SELL
$46.4 - $67.43 $66,676 - $96,896
-1,437 Reduced 4.17%
33,035 $1.84 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $252,496 - $329,358
5,131 Added 17.49%
34,472 $2.21 Million
Q3 2019

Nov 01, 2019

SELL
$42.77 - $50.71 $21,128 - $25,050
-494 Reduced 1.66%
29,341 $1.49 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $93,969 - $103,910
-2,106 Reduced 6.59%
29,835 $1.35 Million
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $144,609 - $172,429
-3,205 Reduced 9.12%
31,941 $1.52 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $113,854 - $147,642
-2,335 Reduced 6.23%
35,146 $1.83 Million
Q3 2018

Nov 02, 2018

SELL
$55.19 - $62.25 $60,598 - $68,350
-1,098 Reduced 2.85%
37,481 $2.33 Million
Q2 2018

Jul 27, 2018

SELL
$50.53 - $62.98 $7.76 Million - $9.67 Million
-153,579 Reduced 79.92%
38,579 $2.14 Million
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $560,371 - $645,100
-9,352 Reduced 4.64%
192,158 $12.2 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $2.77 Million - $3.02 Million
46,172 Added 29.72%
201,510 $12.3 Million
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $254,168 - $293,331
-4,602 Reduced 2.88%
155,338 $9.9 Million
Q2 2017

Aug 10, 2017

BUY
N/A
159,940
159,940 $8.91 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.